Effectiveness of a Paleolithic Based Diet Compared to MyPlate Guidelines, With and Without Exercise, in Women.

November 15, 2016 updated by: Elliot D. Jesch, Clemson University

The Effectiveness of a Paleolithic Based Diet Compared to MyPlate Guidelines, With and Without Exercise, on Physical Conditioning in Women: a Randomized Controlled Trial.

The purpose of this study is to determine the effectiveness of recommending either a Paleolithic based diet or the United States Department of Agriculture MyPlate guidelines with or without exercise on physical conditioning, hormones related to energy metabolism, body composition, resting energy expenditure, blood biomarkers, and urine in young, adult females.

Study Overview

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • South Carolina
      • Clemson, South Carolina, United States, 29631
        • Clemson University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • body fat percent between 20 and 38
  • less than 150 minutes of exercise per week at 4.5 or greater Metabolic Equivalent of Task
  • not pregnant, trying to become pregnant or lactating
  • non-smoker
  • no previous resistance training
  • have not been on a diet in the past three months
  • no dietary restrictions (food allergies, disease conditions, etc)
  • have not lost more than 10 lbs. in the past three months

Exclusion Criteria:

  • taking any medication
  • women who have had a left breast mastectomy
  • do not meet criteria of PAR-Q

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: MyPlate
To consume a weight maintenance diet based on the United States Department of Agriculture MyPlate nutrition recommendations for eight weeks.
To consume a weight maintenance diet based on the United States Department of Agriculture MyPlate nutrition recommendations for eight weeks.
Active Comparator: MyPlate + Exercise
To consume a weight maintenance diet based on the United States Department of Agriculture MyPlate nutrition recommendations and aerobic and resistance training four days per week for eight weeks.
To consume a weight maintenance diet based on the United States Department of Agriculture MyPlate nutrition recommendations and aerobic and resistance training four days per week for eight weeks.
Active Comparator: Paleolithic
To consume a weight maintenance diet based on alternative (Paleolithic based) nutrition recommendations for eight weeks.
To consume a weight maintenance diet based on alternative (Paleolithic based) nutrition recommendations for eight weeks.
Active Comparator: Paleolithic + Exercise
To consume a weight maintenance diet based on alternative (Paleolithic based) nutrition recommendations and aerobic and resistance training four days per week for eight weeks.
To consume a weight maintenance diet based on alternative (Paleolithic based) nutrition recommendations and aerobic and resistance training four days per week for eight weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in aerobic conditioning
Time Frame: Baseline and 8 weeks
Peak oxygen consumption
Baseline and 8 weeks
Change in anaerobic power
Time Frame: Baseline and 8 weeks
Wingate anaerobic threshold
Baseline and 8 weeks
Change in strength
Time Frame: Baseline and 8 weeks
Chest press and leg press estimated one repetition maximum
Baseline and 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in resting energy expenditure
Time Frame: Baseline and 8 weeks
24 hour kcal and respiratory quotient
Baseline and 8 weeks
Change in urine
Time Frame: Baseline and 8 weeks
Osmolality
Baseline and 8 weeks
Change in insulin (plasma)
Time Frame: Baseline and 8 weeks
Radioimmunoprecipitation assay
Baseline and 8 weeks
Change in glucagon (plasma)
Time Frame: Baseline and 8 weeks
Radioimmunoprecipitation assay
Baseline and 8 weeks
Change in ghrelin (plasma)
Time Frame: Baseline and 8 weeks
Total and active ghrelin; Radioimmunoprecipitation assay
Baseline and 8 weeks
Change in peptide YY 3-36 (plasma)
Time Frame: Baseline and 8 weeks
Radioimmunoprecipitation assay
Baseline and 8 weeks
Change in adiponectin (plasma)
Time Frame: Baseline and 8 weeks
Radioimmunoprecipitation assay
Baseline and 8 weeks
Change in leptin (plasma)
Time Frame: Baseline and 8 weeks
Radioimmunoprecipitation assay
Baseline and 8 weeks
Change in tumor necrosis factor alpha (plasma)
Time Frame: Baseline and 8 weeks
ELISA
Baseline and 8 weeks
Change in interleukin 6 (plasma)
Time Frame: Baseline and 8 weeks
ELISA
Baseline and 8 weeks
Change in undercarboxylated osteocalcin (plasma)
Time Frame: Baseline and 8 weeks
enzymeimmunoassay
Baseline and 8 weeks
Change in total cholesterol (plasma)
Time Frame: Baseline and 8 weeks
Colorimetric enzyme assay
Baseline and 8 weeks
Change in HDL cholesterol (plasma)
Time Frame: Baseline and 8 weeks
Colorimetric enzyme assay
Baseline and 8 weeks
Change in non-HDL cholesterol (plasma)
Time Frame: Baseline and 8 weeks
Calculated from triacylglycerol, total cholesterol and HDL cholesterol
Baseline and 8 weeks
Change in triacylglycerol (plasma)
Time Frame: Baseline and 8 weeks
Colorimetric enzyme assay
Baseline and 8 weeks
Change in non-esterified fatty acids (plasma)
Time Frame: Baseline and weeks
Colorimetric enzyme assay
Baseline and weeks
Change in glucose (plasma)
Time Frame: Baseline and 8 weeks
Colorimetric enzyme assay
Baseline and 8 weeks
Change in ketones (plasma)
Time Frame: Baseline and 8 weeks
Colorimetric enzyme assay
Baseline and 8 weeks
Change in fat mass
Time Frame: Baseline and 8 weeks
Dual energy x-ray absorptiometry
Baseline and 8 weeks
Change in fat free mass
Time Frame: Baseline and 8 weeks
Dual energy x-ray absorptiometry
Baseline and 8 weeks
Change in bone mass
Time Frame: Baseline and 8 weeks
Dual energy x-ray absorptiometry
Baseline and 8 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in free living activity
Time Frame: Baseline and 8 weeks
Armband activity monitor worn on the upper left arm (METs)
Baseline and 8 weeks
Change in blood pressure
Time Frame: Baseline and 8 weeks
Systolic and diastolic blood pressure
Baseline and 8 weeks
Change in resting heart rate
Time Frame: Baseline and 8 weeks
Beats per minute
Baseline and 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2015

Primary Completion (Actual)

May 1, 2016

Study Completion (Actual)

May 1, 2016

Study Registration Dates

First Submitted

February 16, 2015

First Submitted That Met QC Criteria

March 2, 2015

First Posted (Estimate)

March 5, 2015

Study Record Updates

Last Update Posted (Estimate)

November 17, 2016

Last Update Submitted That Met QC Criteria

November 15, 2016

Last Verified

November 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • IRB2014-457

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on MyPlate

Subscribe